How to deliver complex drugs easily, automatically and safely?

The pharmaceutical industry has undergone a remarkable shift in the delivery route for pharmaceutical products, with injectable drugs taking center stage. According to the U.S. Food and Drug Administration (FDA), injectables now account for 40% of newly approved drugs, primarily administered via subcutaneous and intramuscular routes. This paradigm shift necessitates new strategies that prioritize patient-centric approaches to enhance treatment adherence.

Read more
team eveon

Meet EVEON, Spring 2023

EVEON is attending in various events this Spring 2023. Save the dates and come to meet us and discuss about your needs and how adaptive optics can improve your projects.

Read more

Feasibility of intratumoral delivery

EVEON contributes to studies about feasibility of intratumoral delivery to induced glioblastoma, in a large animal model. EVEON developed the preclinical injection system for this project. Work on this subject has been published in the journal Plos One.

Read more